adagrasib,cetuximab
mirati therapeutics,eli lilly
['crcsm', 'adagrasib', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)']
the #oncoalerttoptweet day2 of #aacr23
tweet by our faculty dr. pasi janne showed that in kras g12c the combination of adagrasib + cetuxmab was effective with a 4 6 % response rate and with no added tox #crcsm #kras best, 
🌐 Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees 🌎 We are #OncoAlert 🚨